Quantitative Investment Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-19,029
Closed -$346K 539
2021
Q2
$346K Buy
19,029
+7,778
+69% +$138K 0.03% 319
2021
Q1
$195K Sell
11,251
-22,948
-67% -$404K 0.02% 459
2020
Q4
$594K Buy
+34,199
New +$546K 0.05% 309
2020
Q1
Sell
-92,056
Closed -$1.96M 785
2019
Q4
$1.96M Sell
92,056
-39,172
-30% -$877K 0.06% 317
2019
Q3
$3.01M Buy
131,228
+18,562
+16% +$396K 0.16% 175
2019
Q2
$2.22M Buy
112,666
+97,466
+641% +$1.9M 0.09% 262
2019
Q1
$295K Sell
15,200
-42,900
-74% -$813K 0.02% 563
2018
Q4
$957K Buy
58,100
+28,700
+98% +$578K 0.05% 290
2018
Q3
$679K Buy
+29,400
New +$666K 0.02% 369

Other funds holding SBRA

Quantitative Investment Management's SBRA Position: Q3 2021 in Review

Quantitative Investment Management sold out of Sabra Healthcare REIT (SBRA) in Q3 2021, closing a stake of 19,029 shares — an estimated $346K sold.

Quantitative Investment Management first reported a position in SBRA in Q3 2018 and held it in 9 quarters. The position peaked at $3.01M in Q3 2019. 326 funds tracked by Wall St. Rank hold SBRA as of Q3 2021.

  • Quantitative Investment Management reported no remaining Sabra Healthcare REIT position as of Q3 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 19,029 Sabra Healthcare REIT shares in Q3 2021, an estimated $346K.
  • Quantitative Investment Management first reported a position in Sabra Healthcare REIT in Q3 2018 and held it in 9 quarters.
  • Quantitative Investment Management's Sabra Healthcare REIT position peaked at $3.01M in Q3 2019.
  • 326 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2021.

Based on Quantitative Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.